Decrescent role of recombinant HSP60 antibody against atherosclerosis in high-cholesterol diet immunized rabbits

Document Type : Original Article


1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Department of Paraclinic, School of Medicine, Herat University, Herat, Afghanistan

3 Department of Biotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University (IAUPS), Tehran, Iran

4 Department of Plant Bioproducts, Institute of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

5 Department of Genetics, Islamic Azad University, Varamin Pishva Branch, Tehran, Iran

6 Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran


Objective(s): Atherosclerosis is the main cause of cardiovascular disease (CVD) which has a key role in the development of coronary artery disease (CAD). Based on clinical studies, HSP60 is the only HSP that can cause atherosclerosis. In this paper, the expression level of HSP60 and the pathogenic degree of its cloned part was investigated in atherosclerosis condition.
Materials and Methods:  After the designation of the specific primers for HSP60, PCR was done by the Pfu enzyme. Subsequently, the PCR products were cloned into a prokaryotic expression vector pET-28a. The resultant recombinant vector was transferred in BL21 and purified. Purification of protein was done by the Nickel affinity column. After confirmation of Western blotting and HSP60 protein purification, purified protein concentration was measured by the Bradford method, and purity was analyzed by SDS PAGE 12%. New Zealand rabbits were tested as an animal model. At the next step, the recombinant protein was injected into the animal model that was on a fatty diet.
Results: The prokaryotic expression plasmid pET28a-hps60 was successfully constructed, the HSP60 protein was expressed and purified in Escherichia coli BL21 (DE3). We found that the rabbit that was receiving the recombinant vaccine with the fatty diet showed a lower amount of fat deposition at the media endothelial level than the rabbit which received only the fatty diet. 
Conclusion: Taking recombinant protein concomitant with a fatty diet, causes betterment of atherosclerosis via decreasing aggregation of cholesterol and thickness of the endothelial media.


1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
2. Hansson GK, Libby P. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 2006; 6:508-519.
3. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13:587-596.
4. Harvey EJ, Ramji DP. Interferon-γ and atherosclerosis: pro-or anti-atherogenic? Cardiovasc Res 2005; 67:11-20.
5. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis:
A comprehensive review of studies in mice. Cardiovasc Res 2008; 79:360-376.
6. Sepanlou SG, Newson RB, Poustchi H, Malekzadeh MM, Asl PR, Etemadi A, et al. Cardiovascular disease deaths and years of life lost attributable to non-optimal systolic blood pressure and hypertension in Northeastern Iran. Arch Iran Med 2015; 18:144.
7. van Puijvelde GH, van Es T, Van Wanrooij E, Habets K, De Vos P, Van Der Zee R, et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol  2007; 27:2677-2683.
8. Shatilina ZM, Riss HW, Protopopova MV, Trippe M, Meyer EI, Pavlichenko VV, et al. The role of the heat shock proteins (HSP70 and sHSP) in the thermotolerance of freshwater amphipods from contrasting habitats. J Therm Biol 2011; 36:142-149.
9. Lu X, Kakkar V. The role of heat shock protein (HSP) in atherosclerosis: Pathophysiology and clinical opportunities. Curr Med Chem 2010; 17:957-973.
10. Kaufman BA, Kolesar JA, Perlman PS, Butow RA. Studies on mitochondrial DNA nucleoids in Saccharomyces cerevisiae: Identification of bifunctional proteins. J Cell Biol 2003; 163:457-461.
11. Ghosh JC, Dohi T, Kang BH, Altieri DC. Hsp60 regulation of tumor cell apoptosis. J Biol Chem 2008; 283:5188-5194.
12. Zininga T, Ramatsui L, Shonhai A. Heat shock proteins as immunomodulants. Molecules 2018; 23:2846.
13. Kim DS, Ko YJ, Lee MW, Park HJ, Park YJ, Kim D-I, et al. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Cell Stress Chaperones 2016; 21:1089-1099.
14. Urban-Chmiel R, Dec M, Puchalski A, Wernicki A. Characterization of heat-shock proteins in Escherichia coli strains under thermal stress in vitro. J Med microbiol 2013; 62:1897-1901.
15. Wick C. Tolerization against atherosclerosis using heat shock protein 60. Cell Stress Chaperones 2016; 21:201-211.
16. Jia C, Ma X, Liu Z, Gu J, Zhang X, Li D, et al. Different Heat Shock Proteins Bind α-Synuclein With Distinct Mechanisms and Synergistically Prevent Its Amyloid Aggregation. Front Neurosci 2019; 13.
17. Huang X, Dong H, Ting Z. Cloning, expression of a truncated HSP110 protein that augments the activities of tumor antigen-specific cytotoxic and apoptosis via tHSP110-peptide complex vaccines. Int J Clin Exp Pathol 2017; 10:10304-10314.
18. Zhang X, He M, Cheng L, Chen Y, Zhou L, Zeng H, et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation 2008; 118:2687-2693.
19. Zhang Y, Xiong Q, Hu X, Sun Y, Tan X, Zhang H, et al. A novel atherogenic epitope from Mycobacterium tuberculosis heat shock protein 65 enhances atherosclerosis in rabbit and LDL receptor-deficient mice. Heart Vessels 2012; 27:411-418.
20. Ghayour-Mobarhan M, Lamb DJ, Tavallaie S, Ferns GA. Relationship between plasma cholesterol, von Willebrand factor concentrations, extent of atherosclerosis and antibody titres to heat shock proteins-60, -65 and -70 in cholesterol-fed rabbits. Int J Exp Pathol 2007; 88:249-255.
21. Khera AV, Cuchel M, De La Llera-Moya M, Rodrigues A, Burke MF, Jafri K, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127-135.
22. Gaofu Q, Jun L, Xiuyun Z, Wentao L, Jie W, Jingjing L. Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model. Life Sci 2005; 77:2690-2702.
23. George J, Afek A, Gilburd B, Shoenfeld Y, Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll of Cardiol 2001; 38:900-905.
24. Ghayour-Mobarhan M, Rahsepar A, Tavallaie S, Rahsepar S, Ferns G. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem 2009; 48:27-72.
25. Lamb DJ, Ferns GA. The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis 2002; 165:231-240.